Whether you need peripheral blood panels, a comprehensive diagnosis on a bone marrow biopsy, or a “hard to find” molecular assay, we power innovative solutions to address the specific needs of your practice or laboratory with our comprehensive menu of routine and specialized hematopathology testing services.
Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow that progresses very quickly. Therefore, prompt diagnosis improves outcomes.
Quest Diagnostics employs the FISH panel to identify the TEL/AML1 gene fusion that is usually undetectable by conventional chromosome analysis used to screen for acute lymphoblastic leukemia (ALL).
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. In some cases, the disease can be aggressive and within a year the tumor mass may increase significantly imposing serious health problems to the patient.
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow.1
This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.
References
Find out what's happening
Quest offers its clients a dedicated oncology customer support line to assist with any test-related questions.
Contact our dedicated customer service team at: 1.833.773.1441
The Quest Hereditary Cancer Screening test portfolio offers you and your patients insights into hereditary risk so you can make more informed decisions together.